NASDAQ:MBRX - Moleculin Biotech, Inc.
$1.17
 $-0.01
-0.85%
11:45AM EDT
2019-07-22
Moleculin Biotech, Inc. is a preclinical-stage pharmaceutical company. The Company is focused on the development of anti-cancer drug candidates. Its lead drug candidate is liposomal Annamycin, which it refers to as Annamycin, an anthracycline intended for the treatment of relapsed or refractory acute myeloid leukemia (AML). Annamycin is a Phase II clinical-stage anthracycline and liposome formulated anthracycline that has been designed to eliminate cardiotoxicity and avoid the multidrug resistance mechanisms. It has over two other drug development projects in progress, one involving a portfolio of small molecules, which it refers to as the WP1066 Portfolio, focused on the modulation of key oncogenic transcription factors involved in the progression of cancer, and the WP1122 Portfolio, a suite of molecules targeting the metabolic processes involved in cancer in general, and glioblastoma. As of April 3, 2017, it had not generated any revenue from its operations. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  MBRX     avg for
industry  
  avg for
sector  
42 stocks weight:  4. 82   217. 37   399. 45  
42 stocks rank:  4. 25 K 1. 27 K 716. 99  
# analyst opinions:  2. 00   13. 21   13. 71  
mean recommendation:  2. 00   2. 10   2. 04  

quick ratio:  1. 36   5. 49   1. 88  
current ratio:  1. 49   5. 87   2. 36  

target price low:  3. 00   83. 44   114. 90  
target price avg:  1. 75   106. 20   137. 90  
target price high:  0. 80   132. 30   158. 97  
1-yr high:  2. 98   111. 86   142. 57  
last close:  1. 18   86. 79   125. 44  
50-day avg:  1. 20   86. 68   122. 63  
200-day avg:  1. 26   89. 22   121. 38  
1-yr low:  0. 81   69. 78   100. 51  
volume:  399. 91 K 2. 62 M 3. 43 M
50-day avg volume:  494. 98 K 3. 20 M 4. 16 M
200-day avg volume:  1. 42 M 2. 99 M 4. 75 M

1-day return:  -2. 36 % -1. 30 % -0. 99 %
this week return:  -7. 81 % 0. 45 % -0. 20 %
12-wk return:  -16. 90 % 0. 94 % 4. 84 %
52-wk return:  -30. 64 % -1. 30 % 10. 55 %

enterprise value (EV):  44. 76 M 45. 10 B 122. 38 B
market cap:  53. 33 M 38. 96 B 108. 40 B
EBITDA:  -16. 85 M 4. 20 B 8. 19 B
enterprise multiple (EV/EBITDA):  -2. 66   5. 38   11. 93  
total debt:  213. 00 K 10. 90 B 17. 48 B
debt/equity:  1. 45   57. 18   120. 05  
net income (common):  -13. 99 M 2. 07 B 4. 05 B

shares outstanding:  0. 00   538. 09 M 1. 24 B
shares:  31. 10 M 548. 00 M 1. 22 B
shares short:  2. 54 M 10. 98 M 11. 87 M
shares short prior month:  2. 42 M 9. 32 M 12. 05 M
short ratio:  6. 09   5. 60   3. 34  
short % of float:  9. 26 % 6. 48 % 2. 64 %
total cash/share:  0. 19   10. 98   9. 19  
total cash:  8. 78 M 5. 93 B 6. 10 B
free cash flow:  -5. 18 M 2. 92 B 4. 55 B
operating cash flow:  -13. 24 M 3. 80 B 5. 78 B

book value:  0. 43   13. 35   27. 45  
price/book:  2. 76   4. 60   8. 78  
operating margins:  0. 00 % -308. 40 % -28. 55 %
EBITDA margins:  0. 00 % 13. 17 % 23. 38 %
profit margins:  0. 00 % 10. 44 % 14. 18 %
gross margins:  0. 00 % 35. 80 % 55. 40 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 66 % 1. 03 %

1-yr EPS:  -0. 51   2. 10   4. 23  
forward EPS:  -0. 45   3. 45   7. 10  
P/E:  -2. 30   1. 90   32. 10  
forward P/E:  -2. 62   6. 46   15. 47  
PE/G:  0. 10   0. 70   -0. 54  
growth:  -22. 99 % 265. 63 % 79. 11 %
earnings high:  -0. 09   0. 89   1. 68  
earnings avg:  -0. 10   0. 70   1. 57  
earnings low:  -0. 12   0. 46   1. 46  
revenue high:  -0. 00   2. 57 B 11. 07 B
revenue avg:  -0. 00   2. 51 B 10. 91 B
revenue low:  -0. 00   2. 45 B 10. 73 B
return on assets:  -45. 86 % -2. 34 % 5. 28 %
return on equity:  -79. 37 % -90. 08 % 133. 53 %

beta (1yr vs S&P500):  0. 79   1. 27   0. 91  
sharpe (1yr):  0. 38   0. 16   0. 77  

held % insiders:  23. 73 % 6. 06 % 3. 29 %
held % institutions:  11. 23 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : MBRX
.    101.054 =       101.054 :: --> INITIAL WEIGHT <--
.    - 0.512 =       100.542 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.025 =       203.567 :: P/E factor
.    x 1.777 =        361.79 :: PE/G factor
.    x 1.621 =       586.395 :: beta factor
.    x 0.776 =       454.793 :: sharpe factor
.    x 2.255 =      1025.376 :: current ratio factor
.    x 1.629 =      1670.832 :: quick ratio factor
.    x 1.079 =      1802.799 :: short ratio factor
.    x 1.025 =      1847.727 :: price-to-book factor
.    x 1.013 =      1871.023 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.121 =      3968.054 :: sector+industry 1-year gains factor
.    x 1.009 =      4005.465 :: industry 12-weeks return factor
.    x 1.308 =      5238.701 :: industry 2-weeks return factor
.    x 1.069 =      5600.469 :: 5-day avg > 50-day avg
.    x 0.974 =      5452.909 :: "drift" penalty 1 days ago
.    x 0.997 =      5438.733 :: "drift" penalty 2 days ago
.    / 2.133 =      2549.971 :: overall "drift" factor
.    x 0.876 =      2233.204 :: largest single-day jump factor
.    x 0.062 =       139.575 :: low price factor
.     x 0.27 =        37.681 :: notable returns + performance factor
.                               --> PROJECTIONS <--
.    x 0.203 =          7.63 :: forward EPS factor
.     x 0.71 =         5.419 :: forward P/E factor
.    x 1.185 =          6.42 :: industry recommendation factor
.    x 2.098 =        13.471 :: company recommendation factor
.    x 1.003 =        13.508 :: factor historical industry gain for week 29
.   x 10.675 =       144.199 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =         3.465 :: reduced for readability
.     + 1.35 =         4.815 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                      4.815 :: FINAL WEIGHT for NASDAQ:MBRX


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org